Literature DB >> 21801852

Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.

Kazuhito Tsuboi1, Yasuo Okamoto, Natsuki Ikematsu, Manami Inoue, Yoshibumi Shimizu, Toru Uyama, Jun Wang, Dale G Deutsch, Matthew P Burns, Nadine M Ulloa, Akira Tokumura, Natsuo Ueda.   

Abstract

Bioactive N-acylethanolamines include anandamide (an endocannabinoid), N-palmitoylethanolamine (an anti-inflammatory), and N-oleoylethanolamine (an anorexic). In the brain, these molecules are formed from N-acylphosphatidylethanolamines (NAPEs) by a specific phospholipase D, called NAPE-PLD, or through NAPE-PLD-independent multi-step pathways, as illustrated in the current study employing NAPE-PLD-deficient mice. Although N-acylethanolamine plasmalogen (1-alkenyl-2-acyl-glycero-3-phospho(N-acyl)ethanolamine, pNAPE) is presumably a major class of N-acylethanolamine phospholipids in the brain, its enzymatic conversion to N-acylethanolamines is poorly understood. In the present study, we focused on the formation of N-acylethanolamines from pNAPEs. While recombinant NAPE-PLD catalyzed direct release of N-palmitoylethanolamine from N-palmitoylethanolamine plasmalogen, the same reaction occurred in the brain homogenate of NAPE-PLD-deficient mice, suggesting that this reaction occurs through both the NAPE-PLD-dependent and -independent pathways. Liquid chromatography-mass spectrometry revealed a remarkable accumulation of 1-alkenyl-2-hydroxy-glycero-3-phospho(N-acyl)ethanolamines (lyso pNAPEs) in the brain of NAPE-PLD-deficient mice. We also found that brain homogenate formed N-palmitoylethanolamine, N-oleoylethanolamine, and anandamide from their corresponding lyso pNAPEs by a Mg(2+)-dependent "lysophospholipase D". Moreover, the brain levels of alkenyl-type lysophosphatidic acids, the other products from lyso pNAPEs by lysophospholipase D, also increased in NAPE-PLD-deficient mice. Glycerophosphodiesterase GDE1 can hydrolyze glycerophospho-N-acylethanolamines to N-acylethanolamines in the brain. In addition, we discovered that recombinant GDE1 has a weak activity to generate N-palmitoylethanolamine from its corresponding lyso pNAPE, suggesting that this enzyme is at least in part responsible for the lysophospholipase D activity. These results strongly suggest that brain tissue N-acylethanolamines, including anandamide, can be formed from N-acylated plasmalogen through an NAPE-PLD-independent pathway as well as by their direct release via NAPE-PLD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801852     DOI: 10.1016/j.bbalip.2011.07.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS.

Authors:  Waldemar Röhrig; Susanne Achenbach; Birgit Deutsch; Monika Pischetsrieder
Journal:  J Lipid Res       Date:  2019-06-24       Impact factor: 5.922

2.  Phospholipid profiles of control and glaucomatous human aqueous humor.

Authors:  Genea Edwards; Katyayini Aribindi; Yenifer Guerra; Richard K Lee; Sanjoy K Bhattacharya
Journal:  Biochimie       Date:  2014-02-21       Impact factor: 4.079

3.  The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.

Authors:  Partha Mukhopadhyay; Marc Baggelaar; Katalin Erdelyi; Zongxian Cao; Resat Cinar; Filomena Fezza; Bogna Ignatowska-Janlowska; Jenny Wilkerson; Noortje van Gils; Thomas Hansen; Marc Ruben; Marjolein Soethoudt; Laura Heitman; George Kunos; Mauro Maccarrone; Aron Lichtman; Pál Pacher; Mario Van der Stelt
Journal:  Br J Pharmacol       Date:  2016-01-15       Impact factor: 8.739

4.  ABHD4 regulates multiple classes of N-acyl phospholipids in the mammalian central nervous system.

Authors:  Hyeon-Cheol Lee; Gabriel M Simon; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2015-04-08       Impact factor: 3.162

Review 5.  Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.

Authors:  Natalie E Zlebnik; Joseph F Cheer
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

6.  Generation of N-acylphosphatidylethanolamine by members of the phospholipase A/acyltransferase (PLA/AT) family.

Authors:  Toru Uyama; Natsuki Ikematsu; Manami Inoue; Naoki Shinohara; Xing-Hua Jin; Kazuhito Tsuboi; Takeharu Tonai; Akira Tokumura; Natsuo Ueda
Journal:  J Biol Chem       Date:  2012-07-23       Impact factor: 5.157

Review 7.  Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Authors:  Maria Scherma; Anna Lisa Muntoni; Miriam Melis; Liana Fattore; Paola Fadda; Walter Fratta; Marco Pistis
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

Review 8.  An Introduction to the Endogenous Cannabinoid System.

Authors:  Hui-Chen Lu; Ken Mackie
Journal:  Biol Psychiatry       Date:  2015-10-30       Impact factor: 13.382

9.  Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.

Authors:  Emma Leishman; Ken Mackie; Serge Luquet; Heather B Bradshaw
Journal:  Biochim Biophys Acta       Date:  2016-03-05

Review 10.  The evolution and comparative neurobiology of endocannabinoid signalling.

Authors:  Maurice R Elphick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.